TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 307 filers reported holding TANDEM DIABETES CARE INC in Q2 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $243,000 | -18.5% | 2,092 | +5.7% | 0.00% | 0.0% |
| Q4 2021 | $298,000 | +16.0% | 1,980 | -8.1% | 0.00% | 0.0% |
| Q3 2021 | $257,000 | +22.4% | 2,154 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $210,000 | +4.0% | 2,154 | -6.0% | 0.00% | 0.0% |
| Q1 2021 | $202,000 | -18.9% | 2,292 | -12.1% | 0.00% | 0.0% |
| Q4 2020 | $249,000 | -35.2% | 2,607 | -22.9% | 0.00% | -50.0% |
| Q3 2020 | $384,000 | -41.1% | 3,382 | -48.7% | 0.00% | -33.3% |
| Q2 2020 | $652,000 | -63.7% | 6,592 | -76.4% | 0.00% | -72.7% |
| Q1 2020 | $1,794,000 | +134.5% | 27,885 | +117.3% | 0.01% | +175.0% |
| Q4 2019 | $765,000 | +12.2% | 12,830 | +11.0% | 0.00% | 0.0% |
| Q3 2019 | $682,000 | +185.4% | 11,560 | +212.4% | 0.00% | +300.0% |
| Q2 2019 | $239,000 | -46.8% | 3,700 | -47.7% | 0.00% | -50.0% |
| Q1 2019 | $449,000 | – | 7,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,022,257 | $60,293,000 | 5.97% |
| APIS CAPITAL ADVISORS, LLC | 50,000 | $2,949,000 | 4.62% |
| SECTORAL ASSET MANAGEMENT INC | 432,815 | $25,527,000 | 4.40% |
| CROWN ADVISORS MANAGEMENT, INC. | 75,000 | $4,424,000 | 2.96% |
| OBERWEIS ASSET MANAGEMENT INC/ | 199,410 | $11,761,000 | 2.66% |
| Asymmetry Capital Management, L.P. | 18,995 | $1,120,000 | 2.40% |
| Redmile Group, LLC | 1,160,401 | $68,440,000 | 2.29% |
| FRIESS ASSOCIATES LLC | 501,985 | $29,607,000 | 2.29% |
| Atika Capital Management LLC | 142,000 | $8,375,000 | 1.76% |
| Chicago Capital, LLC | 433,083 | $25,543,000 | 1.71% |